MingMed Biotech

Guangzhou, China · Founded 2019 · Privately Held (backing)

Developer of pharmaceutical drugs intended for global pharmaceutical markets and healthcare providers. MingMed Biotech is based in Guangzhou, China and was founded in 2019. Its last reported valuation was $615 million in Jul 2022. It has raised $140 million.

Last reported valuation

$615.4M

Oct 2026

Priced at

—

Total raised

$139.8M

Last round

—

How much has MingMed Biotech raised?

$139.8Macross 0 recorded rounds

Free account

More of MingMed Biotech with a free account

·The complete investor list: 16 names
·Watch MingMed Biotech: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

MingMed Biotech investors

16 investors are on record for MingMed Biotech, including CAS Star, Shenzhen Yifeng Investment Management Enterprise, Oceanpine Capital and Hengqin Financial Investment.

For fundraisers

Raising for a company like MingMed Biotech?

16 investors have backed MingMed Biotech.

See all 16 investors →

Frequently asked about MingMed Biotech

How much has MingMed Biotech raised?: MingMed Biotech has raised $139.8M in total across 0 recorded funding rounds.